Shanghai Hile Bio-Technology Co (SHSE:603718) Accounts Payable & Accrued Expense : ¥290.5 Mil (As of Jun. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Shanghai Hile Bio-Technology Co Accounts Payable & Accrued Expense?

Shanghai Hile Bio-Technology Co's quarterly accounts payable & accrued expense declined from Dec. 2023 (¥344.0 Mil) to Mar. 2024 (¥314.9 Mil) and declined from Mar. 2024 (¥314.9 Mil) to Jun. 2024 (¥290.5 Mil).

Shanghai Hile Bio-Technology Co's annual accounts payable & accrued expense declined from Dec. 2021 (¥624.3 Mil) to Dec. 2022 (¥278.5 Mil) but then increased from Dec. 2022 (¥278.5 Mil) to Dec. 2023 (¥344.0 Mil).

Shanghai Hile Bio-Technology Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Shanghai Hile Bio-Technology Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Hile Bio-Technology Co Accounts Payable & Accrued Expense Chart

Shanghai Hile Bio-Technology Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

586.27

604.72

624.35

278.48

344.01

Shanghai Hile Bio-Technology Co Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															316.79	305.87	344.01	314.87	290.51

Shanghai Hile Bio-Technology Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Shanghai Hile Bio-Technology Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Hile Bio-Technology Co Ltd (SHSE:603718) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Shanghai Jinhai Road 6720, Shanghai, CHN, 201403

Website

http://www.hile-bio.com

Shanghai Hile Bio-Technology Co Ltd is a veterinary biological product manufacturer integrating research and development, production, sales, and service. The company has over 40 categories of poultry, livestock, and pets. The company provides services for the prevention of livestock diseases, improving the health of livestock and poultry, and improving the production efficiency of farmers, and is able to provide comprehensive solutions and an authoritative veterinary expert service system.

Executives

Zhang Lu	Director
Liu Han Ping	Directors, senior managers
Zhou Yu Sheng	Supervisors
Zhang Hai Ming	Director
Sun Guo Bao	Supervisors
Zhang Yue	Director
Su Bin	Director
Wu Ling Yue	senior management

Shanghai Hile Bio-Technology Co Headlines

No Headlines